Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Beckmann

Showing results (771-780 of 1,041) with videos related to

Pageof 105
Sort By:
Human Molecular Genetics|February 14, 2022
Genome-wide association study and functional follow-up identify 14q12 as a candidate risk locus for cervical cancerDhanya Ramachandran, Joe Dennis, Laura Fachal, et al.
Breast Cancer Research : BCR|October 24, 2020
Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer-results from the randomized phase III SUCCESS-A trialAmelie de Gregorio, Lothar Häberle, Peter A Fasching, et al.
Cell|August 29, 2015
Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous RetrovirusesKatherine B Chiappinelli, Pamela L Strissel, Alexis Desrichard, et al.
International Journal of Cancer|April 25, 2025
Limited association between HRR gene alterations and HRD in molecular tumor board cancer samples: Who should be tested for HRD?Christoph Schubart, Lars Tögel, Maria Giulia Carta, et al.
Breast Care (Basel, Switzerland)|November 12, 2015
14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German ExpertsChristian Jackisch, Nadia Harbeck, Jens Huober, et al.
Breast (Edinburgh, Scotland)|December 15, 2017
Impact of disease progression on health-related quality of life in patients with metastatic breast cancer in the PRAEGNANT breast cancer registryVolkmar Müller, Naiba Nabieva, Lothar Häberle, et al.
Geburtshilfe Und Frauenheilkunde|July 14, 2015
Primary Therapy of Patients with Early Breast Cancer: Evidence, Controversies, Consensus: Opinions of German Specialists to the 14th St. Gallen International Breast Cancer Conference 2015 (Vienna 2015)M Untch, N Harbeck, J Huober, et al.
Breast Care (Basel, Switzerland)|June 29, 2018
TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients - First Results on the Influence of Tumor-Infiltrating LymphocytesFranziska Würfel, Ramona Erber, Hanna Huebner, et al.
Journal for Immunotherapy of Cancer|June 26, 2021
Identification and validation of expressed HLA-binding breast cancer neoepitopes for potential use in individualized cancer therapyHannah Reimann, Andrew Nguyen, J Zachary Sanborn, et al.
International Journal of Molecular Sciences|August 12, 2022
Molecular Subtyping of Invasive Breast Cancer Using a PAM50-Based Multigene Expression Test-Comparison with Molecular-Like Subtyping by Tumor Grade/Immunohistochemistry and Influence on Oncologist's Decision on Systemic Therapy in a Real-World SettingRamona Erber, Miriam Angeloni, Robert Stöhr, et al.
Pageof 105

Showing results (771-780 of 1,041) with videos related to

Sort By:
Pageof 105
Human Molecular Genetics|February 14, 2022
Genome-wide association study and functional follow-up identify 14q12 as a candidate risk locus for cervical cancerDhanya Ramachandran, Joe Dennis, Laura Fachal, et al.
Breast Cancer Research : BCR|October 24, 2020
Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer-results from the randomized phase III SUCCESS-A trialAmelie de Gregorio, Lothar Häberle, Peter A Fasching, et al.
Cell|August 29, 2015
Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous RetrovirusesKatherine B Chiappinelli, Pamela L Strissel, Alexis Desrichard, et al.
International Journal of Cancer|April 25, 2025
Limited association between HRR gene alterations and HRD in molecular tumor board cancer samples: Who should be tested for HRD?Christoph Schubart, Lars Tögel, Maria Giulia Carta, et al.
Breast Care (Basel, Switzerland)|November 12, 2015
14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German ExpertsChristian Jackisch, Nadia Harbeck, Jens Huober, et al.
Breast (Edinburgh, Scotland)|December 15, 2017
Impact of disease progression on health-related quality of life in patients with metastatic breast cancer in the PRAEGNANT breast cancer registryVolkmar Müller, Naiba Nabieva, Lothar Häberle, et al.
Geburtshilfe Und Frauenheilkunde|July 14, 2015
Primary Therapy of Patients with Early Breast Cancer: Evidence, Controversies, Consensus: Opinions of German Specialists to the 14th St. Gallen International Breast Cancer Conference 2015 (Vienna 2015)M Untch, N Harbeck, J Huober, et al.
Breast Care (Basel, Switzerland)|June 29, 2018
TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients - First Results on the Influence of Tumor-Infiltrating LymphocytesFranziska Würfel, Ramona Erber, Hanna Huebner, et al.
Journal for Immunotherapy of Cancer|June 26, 2021
Identification and validation of expressed HLA-binding breast cancer neoepitopes for potential use in individualized cancer therapyHannah Reimann, Andrew Nguyen, J Zachary Sanborn, et al.
International Journal of Molecular Sciences|August 12, 2022
Molecular Subtyping of Invasive Breast Cancer Using a PAM50-Based Multigene Expression Test-Comparison with Molecular-Like Subtyping by Tumor Grade/Immunohistochemistry and Influence on Oncologist's Decision on Systemic Therapy in a Real-World SettingRamona Erber, Miriam Angeloni, Robert Stöhr, et al.
Pageof 105